SNSS Financial Facts

Loss from operations: -7.59M
General and administrative: 2.7M
See Full Income Statement

Total liabilities and stockholders' equity: -118.96M
Deposits and other assets: 10K
See Full Balance Sheet

Sunesis Pharmaceuticals Inc. (SNSS) Earnings

  |   Expand Research on SNSS
Next EPS Date 5/12/14 *Est. EPS Growth Rate +25.0% *Last Qtr.
Average EPS % Beat Rate +11.1% Revenue Growth Rate +0.5% *Last Qtr.
Average % Move 1-Wk after EPS -1.4% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. % Since Details
3/6/14 Q413 -$0.15-$0.20 +$0.05$2M$1.37M N/A -26.3% Details
11/12/13 Q313 -$0.16-$0.20 +$0.04$1.99M$1.44M N/A +1.2% Details
7/29/13 Q213 -$0.18-$0.21 +$0.03$1.99M$1.22M N/A -8.7% Details
5/9/13 Q113 -$0.23-$0.20 -$0.03$1.99M$750K N/A 0% Details
3/13/13 Q412 -$0.20-$0.19 -$0.01$1.99M$320K N/A -4.3% Details
11/8/12 Q312 -$0.37-$0.13 -$0.24$265K$4.17M N/A +38.7% Details
8/9/12 Q212 $0.20-$0.20 +$0.40$1.5MN/A N/A +71.4% Details
5/15/12 Q112 -$0.30-$0.18 -$0.12N/A$90K N/A +93.3% Details